• 1. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 2. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 3. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 4. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 5. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzimidazoles Benzimidazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzimidazoles

Introduction to 5-(Acetoacetamido)-2-benzimidazolinone (CAS No. 26576-46-5)

5-(Acetoacetamido)-2-benzimidazolinone, with the chemical identifier CAS No. 26576-46-5, is a significant compound in the realm of pharmaceutical chemistry and bioorganic synthesis. This heterocyclic compound has garnered attention due to its versatile structural framework, which integrates both the benzimidazole and acetoacetamide moieties. The benzimidazole core is well-documented for its pharmacological properties, while the acetoacetamide substituent introduces reactivity that makes this molecule a valuable intermediate in drug development.

The compound’s unique structure positions it as a promising candidate for various applications, particularly in the synthesis of bioactive molecules. Its ability to undergo functionalization at multiple sites allows chemists to tailor its properties for specific biological targets. Recent advancements in medicinal chemistry have highlighted its potential in designing novel therapeutic agents, particularly those targeting inflammatory and metabolic disorders.

5-(Acetoacetamido)-2-benzimidazolinone has been extensively studied for its role in modulating biological pathways. The benzimidazole moiety is known to interact with nucleic acids and proteins, making it a key scaffold in anticancer and antiviral drug discovery. Meanwhile, the acetoacetamide group can participate in condensation reactions, enabling the formation of more complex derivatives with enhanced pharmacological activity. This dual functionality has been exploited in recent research to develop molecules with improved efficacy and reduced side effects.

In recent years, there has been a surge in interest regarding small molecules that can modulate post-translational modifications (PTMs) of proteins. 5-(Acetoacetamido)-2-benzimidazolinone has emerged as a promising tool in this context, particularly for investigating protein phosphorylation and acetylation. Its structural features allow it to mimic natural substrates or inhibitors of enzymes involved in these processes, providing insights into their mechanisms of action. Such studies are crucial for understanding diseases like diabetes and cancer, where PTMs play a pivotal role.

The compound’s potential extends beyond its role as an intermediate in drug synthesis. It has been explored as a building block for designing metal-organic frameworks (MOFs) and supramolecular assemblies. These materials have applications in catalysis, gas storage, and separation technologies. The benzimidazole ring can act as a ligand for metal ions, while the acetoacetamide group can participate in hydrogen bonding or other non-covalent interactions, facilitating the construction of stable and functional structures.

Recent studies have also highlighted the compound’s role in environmental chemistry. 5-(Acetoacetamido)-2-benzimidazolinone has been used as a probe to study the degradation of pollutants in aquatic systems. Its stability under various conditions makes it an ideal candidate for tracking reactive species generated during the breakdown of toxic compounds. This application underscores its versatility beyond pharmaceuticals and materials science.

The synthesis of 5-(Acetoacetamido)-2-benzimidazolinone involves multi-step organic transformations that showcase modern synthetic methodologies. Advanced techniques such as palladium-catalyzed cross-coupling reactions have been employed to construct the benzimidazole core efficiently. Additionally, asymmetric synthesis strategies have been utilized to obtain enantiomerically pure derivatives, which are essential for drugs targeting chiral biological receptors.

From a computational chemistry perspective, 5-(Acetoacetamido)-2-benzimidazolinone has been subjected to extensive molecular modeling studies. These simulations have provided insights into its interaction with biological targets at an atomic level. Understanding these interactions through computational methods not only accelerates drug discovery but also helps in predicting potential side effects before experimental testing.

The compound’s pharmacokinetic properties have also been evaluated through preclinical studies. Its solubility, stability, and metabolic pathways have been scrutinized to ensure its suitability for therapeutic applications. These studies are critical for translating laboratory findings into viable drug candidates that can progress to clinical trials.

Looking ahead, the future of 5-(Acetoacetamido)-2-benzimidazolinone lies in interdisciplinary research that combines synthetic chemistry with biology and medicine. As our understanding of disease mechanisms evolves, so will the applications of this versatile compound. Whether it continues to serve as a key intermediate or finds new roles in emerging fields like nanotechnology or green chemistry remains an exciting prospect for researchers worldwide.

• 35914-39-7(Butanamide, N,N'-phenylenebis[3-oxo-)
• 501086-24-4(Octanamide,2-acetyl-8-(diethylamino)-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-)
• 13733-33-0(Butanamide,N,N'-1,3-phenylenebis[3-oxo-)
• 91085-68-6(Acetamide,N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-)
• 19766-48-4(1,6-Benzodiazocine-2,5-dione, 1,3,4,6-tetrahydro-)
• 113841-05-7(N-[2,3,4,5,6-pentakis(nonanoylamino)phenyl]nonanamide)
• 89647-52-9(N,2-Dimethyl-4-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-1-carboxamide)
• 63405-80-1(2-Cyano-N-(2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)acetamide)
• 915920-69-3(3-Chloro-N-(2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)propanamide)
• 26736-88-9(Butanamide,N-(2,3-dihydro-1-methyl-2-oxo-1H-benzimidazol-5-yl)-3-oxo-)